Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  NuPathe Inc    PATH   US67059M1009

NUPATHE INC (PATH)

3
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Company
NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
More about the company
Latest news on NUPATHE INC
2014 Analysis - Replay of energetic deal-making seen for drugmakers in 2014
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
2014 NUPATHE INC : NuPathe Inc. Stockholders Encouraged to Contact Securities Law Fir..
2014 S&P 500 ends flat in wake of Fed minutes
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2013 NUPATHE INC : Program Participations and Positive Stock Movements - Research Rep..
More news
Sector news Pharmaceuticals - NEC
02:07p GSK SACKS 110 CHINA STAFF IN WAKE OF : sources
02:04p NOVARTIS : Sandoz cuts workforce by 50 employees
12:24p HOSPIRA : Inflectra™ (infliximab) patient registry reports interim results..
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF